Versatile Emerging infectious disease Observatory

Grant number: 874735

Grant search

Key facts

  • Disease

    Disease X
  • Start & end year

    2020
    2024
  • Known Financial Commitments (USD)

    $20,292,592.32
  • Funder

    European Commission
  • Principal Investigator

    SKIBY Jeffrey
  • Research Location

    Netherlands
  • Lead Research Institution

    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
  • Research Priority Alignment

    N/A
  • Research Category

    13

  • Research Subcategory

    N/A

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Our vision is to establish a Versatile forecasting, nowcasting, and tracking system (VEO) serving as an interactive observatory for the generation and distribution of high quality actionable information for evidence-based early warning, risk assessment and monitoring of Emerging Infectious Diseases and Antimicrobial resistance by public health actors and researchers in the One-Health domain.VEO will be built by an iterative process between data science and technology experts, disease experts from public health and academia, social scientists, and citizen scientists. The VEO data platform will support mining, sharing, integration, presentation and analysis of traditional and novel 'ÄòBio data'Äô with a range of 'ÄúContextual data'Äù, integrating publicly available and confidential data. The VEO analytical platform will support data-intensive interdisciplinary collaboration of geographically distributed international teams, co-creation of novel advanced analytical solutions, and involving citizen scientists through crowdsourcing of specific challenges. In addition, we will develop workflows to integrate high density laboratory data (genomics, phenotyping, immunomics) into the VEO system and into risk assessments. The VEO system is (co)designed and tested through five complementary use case scenarios, reflecting main pathways of disease emergence, to attune developments to the needs of its intended users, and obtain proof-of-principle of utility, including ethical, legal and social implications.

Publicationslinked via Europe PMC

Last Updated:43 minutes ago

View all publications at Europe PMC

The Network of National COVID-19 Data Portals: public health equity through collaboration

SARS-CoV-2 bioaerosol transmission in experimentally infected American mink.

Extreme flood and WNV transmission in Thessaly, Greece, 2023.

Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns.

Language models learn to represent antigenic properties of human influenza A(H3) virus.

Lazypipe3: Customizable Virome Analysis Pipeline Enabling Fast and Sensitive Virus Discovery from NGS data

Pandemic human-associated extended-spectrum β-lactamase-producing Escherichia coli lineages of ST38, ST131 and ST141 identified in Viennese dogs.

Emergence, spread, and impact of high-pathogenicity avian influenza H5 in wild birds and mammals of South America and Antarctica.

Retrospective analysis of clustered neuroinflammatory and neurodegenerative diseases in captive lions in the early 1970s.